David P Smith
Overview
Explore the profile of David P Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
2046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nickel B, Ayre J, Marinovich M, Smith D, Chiam K, Lee C, et al.
Patient Educ Couns
. 2025 Jan;
134():108677.
PMID: 39862490
Objective: This study aimed to assess whether information from AI chatbots on benefits and harms of breast and prostate cancer screening were concordant with evidence-based cancer screening recommendations. Methods: Seven...
2.
Lahoud J, Okullo A, Rutherford C, Smith D, Costa D, Tait M, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39857942
Background/objectives: Knowledge of the symptoms and side effects (SSEs) of Bacille Calmette-Guerin (BCG) therapy for non-muscle invasive bladder cancer (NMIBC) is critical when establishing selecting appropriate therapies for patients. The...
3.
Francis N, Jones S, Smith D
Br J Biomed Sci
. 2025 Jan;
81():14048.
PMID: 39850144
Generative Artificial Intelligence (GenAI) is rapidly transforming the landscape of higher education, offering novel opportunities for personalised learning and innovative assessment methods. This paper explores the dual-edged nature of GenAI's...
4.
Teppala S, Scuffham P, Edmunds K, Roberts M, Fairbairn D, Smith D, et al.
Value Health
. 2024 Jul;
27(11):1515-1527.
PMID: 38977196
Objectives: Patients with metastatic prostate cancer (mPCa) with BReast CAncer gene (BRCA) mutations benefit from targeted treatments (eg, olaparib). In addition, family members of affected patients have increased risk of...
5.
Pearce S, Cross N, Smith D, Clench M, Flint L, Hamm G, et al.
Metabolites
. 2024 Jun;
14(6).
PMID: 38921450
A multimodal mass spectrometry imaging (MSI) approach was used to investigate the chemotherapy drug-induced response of a Multicellular Tumour Spheroid (MCTS) 3D cell culture model of osteosarcoma (OS). The work...
6.
Green A, Newton R, Smith D, Tuffaha H, Galvao D, Heathcote P, et al.
BMJ Open
. 2024 Mar;
14(3):e084412.
PMID: 38521521
Introduction: Androgen deprivation therapy (ADT) is commonly used to treat men with locally advanced or metastatic prostate cancer. Men receiving ADT experience numerous side effects and frequently report unmet supportive...
7.
Serhan M, Psihogios A, Kabir N, Bota A, Mithani S, Smith D, et al.
Hum Vaccin Immunother
. 2024 Feb;
20(1):2293550.
PMID: 38374618
This scoping review examines the role of digital solutions in active, participant-centered surveillance of adverse events following initial release of COVID-19 vaccines. The goals of this paper were to examine...
8.
Lacey M, Francis N, Smith D
FEBS Open Bio
. 2024 Jan;
14(2):230-240.
PMID: 38238067
This study evaluated the use of interactive, branched videos compared with traditional passive linear delivery for enhancing student engagement and learning in online courses. Undergraduate biology students were provided with...
9.
Gallagher B, Chiam K, Bang A, Patel M, Kench J, Edwards S, et al.
Pathology
. 2023 Dec;
56(1):39-46.
PMID: 38104002
Information available from the New South Wales Cancer Registry (NSWCR) about the aggressiveness of prostate cancer is limited to the summary stage variable 'degree of spread', which contains a high...
10.
Mizrahi D, Lai J, Wareing H, Ren Y, Li T, Swain C, et al.
Br J Sports Med
. 2023 Nov;
58(2):97-109.
PMID: 37989539
Objective: To assess the effect of participating in an exercise intervention compared with no exercise during cancer treatment on the duration and frequency of hospital admissions. Design: Systematic review and...